63 results on '"Campieri M"'
Search Results
2. P.08.18 A NEW DEDICATED CAPSULE FOR DIAGNOSIS AND MONITORING OF CROHN'S DISEASE. FIRS PATIENT SERIES
3. P.06.23: Capsule Endoscopy – Accuracy and Prognostic Value of Small Bowel Lesions in Patients with Crohn’s Disease
4. P.11.19: Maintenance of Deep Remission in Patients with Ulcerative Colitis Treated with Thiopurines after Withdrawal of the Drug: Perspective Real-Life Experience of a Single Center
5. OC.11.4 RE-GAIN OF RESPONSE IN CROHN'S DISEASE ADALIMUMAB (ADA) DOSE-ESCALATING FAILURE OR EARLY RELAPSE. A SINGLE CENTRE EXPERIENCE
6. P.08.2 THE LONG-TERM CLINICAL COURSE OF REFRACTORY CHRONIC POUCHITIS AFTER INFLIXIMAB THERAPY
7. P.01.2 ADALIMUMAB FOR THE TREATMENT OF POST-OPERATIVE RECURRENCE OF CROHN'S DISEASE. A SINGLE CENTRE EXPERIENCE
8. CS.02.3 ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTER
9. P.06.2 EFFICACY, SAFETY, IMPACT ON NATURAL HISTORY OF LONG-TERM TREATMENT WITH THIOPURINES IN CROHN'S DISEASE PATIENTS. A SINGLE CENTER EXPERIENCE
10. OC.06.2 LONG-TERM OUTCOME AFTER INFLIXIMAB TREATMENT FOR DISTAL REFRACTORY ULCERATIVE COLITIS. A SINGLE TERTIARY CENTER EXPERIENCE
11. P.05.8 ORAL BECLOMETHASONE DIPROPIONATE IN THE TREATMENT OF CHRONIC REFRACTORY POUCHITIS
12. PC.1.3: IL-33-DEPENDENT INDUCTION OF INTESTINAL PROFIBROTIC GENE EXPRESSION AND MYOFIBROBLAST HYPERTROPHY: POTENTIAL ROLE IN INFLAMMATORY-ASSOCIATED GUT FIBROSIS
13. P.1.23: CELL PROLIFERATION ACTIVITY OF OESOPHAGEAL SQUAMOUS EPITHELIUM IN ERD IS REDUCED COMPARED TO NERD
14. Adult Attachment and Early Parental Experiences in Patients With Crohn's Disease
15. P.70 ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS
16. OC.01.8 USE OF INFLIXIMAB AND ADALIMUMAB IN REFRACTORY POUCHITIS
17. P.17 ROLE OF CB1 IN THE EROSIVE AND NON-EROSIVE GASTRO-ESOPHAGEAL REFLUX DISEASE
18. OC.07.1 ADALIMUMAB IS EFFECTIVE IN THE TREATMENT OF ACTIVE LUMINAL CROHN'S DISEASE AND MUCOSAL HEALING: A SINGLE CENTER EXPERIENCE IN 170 PATIENTS
19. PP33 ADALIMUMAB DOES NOT INFLUENCE PITUITARY ADENOMA IN A CHILD WITH ACTIVE REFRACTORY CROHN'S DISEASE
20. Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: Adhesion properties, competition against enteropathogens and modulation of IL-8 production
21. Medical treatment and management of severe ulcerative colitis
22. T1136 Once-Daily MMX® 5-Aminosalicylic Acid Versus Twice-Daily Asacol® for the Maintenance of Remission of Ulcerative Colitis: A Preliminary Analysis
23. How do biological drugs meet treatment goals in anti-TNF naive patients, in patients with anti-TNF failure and in fistulizing patients?
24. Therapeutic goals in IBD
25. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: A multicenter, randomized, double-blind study
26. Management of pouch dysfunction or pouchitis with an ileoanal pouch
27. Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome
28. Probiotics — Role in inflammatory bowel disease
29. 3 P Probiotic therapy as a prophylaxis in ileo-anal anastomosis patients decreases interferon gamma, interleukin 1 beta and interleukin 8 MRNA expression
30. 78 P High dose of probiotics is effective in the treatment of mild pouchitis. A pilot study
31. 79 OP Ileal pouch anal anastomosis: Pregnancy, delivery and pouch function
32. Oral beclomethasone dipropionate versus oral 5-aminosalicylic acid in the treatment of active ulcerative colitis: A randomised, 4 week, controlled study
33. Highly concentrated probiotics prevent pouchitis onset
34. Quality of life evaluation in patients with ulcerative colitis in a randomized clinical trial: Responsiveness and validity of a disease-specific questionnaire
35. Comparison of oral versus combination mesalazine therapy in active ulcerative colitis: A double-blind, double-dummy, randomized, multi-center Italian study
36. Prophylaxis of postoperative recurrence of Crohn's disease: Combination of antibiotic and probiotic versus mesalazine
37. Chemokine expression in pouchitis
38. Chemokine expression in pouchitis
39. Quality of life evaluation in patients with ulcerative colitis in a randomized clinical trial: Responsiveness and validity of a disease-specific questionnaire
40. Bacteria in pouch tissue
41. Cytokines and ulcerative colitis: Mucosal balance between pro and anti-inflammatory cytokines in patients with and without pouchitis
42. CXC and CC chemokine expression in ulcerative colitis
43. Colonisation of patients with ulcerative colitis (UC) in remission by a new probiotic preparation
44. Maintenance treatment of chronic pouchitis: A randomised placebo-controlled, double-blind trial with A new probiotic preparation
45. Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin in ulcerative colitis
46. Colonic spread and distribution of budesonide foam vs. enema in patients with ulcerative colitis
47. Oral budesonide competes favourably with prednisolone in active Crohn's disease
48. Long-term results of cyclosporine A (CYA) treatment in severe steroid refractory ulcerative colitis (UC)
49. Pentasa in maintenance treatment of ulcerative colitis
50. Effect of a caloric supplement in malnourished patients with Crohn's disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.